News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,544 Results
Type
Article (8075)
Company Profile (140)
Press Release (476328)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52906)
Employer Resources (14)
FDA (9765)
Job Trends (8579)
News (238223)
Policy (17911)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (2)
Allergies (96)
Alliances (33157)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10369)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6964)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
CDC (1)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47862)
Collaboration (1239)
Commercialization (3)
Compensation (1447)
Complete response letters (34)
COVID-19 (770)
CRISPR (63)
C-suite (738)
Cystic fibrosis (85)
Data (5624)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4180)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73654)
Editorial (2)
Employer branding (2)
Employer resources (14)
Events (87580)
Executive appointments (697)
FDA (12371)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (913)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (290)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9316)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (960)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Labor market (1)
Layoffs (61)
Leadership (1)
Legal (5196)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (527)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14378)
Metabolic disorders (704)
mRNA (54)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3151)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41210)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15474)
Phase 2 (21381)
Phase 3 (14399)
Pipeline (7219)
Policy (20)
Postmarket research (1570)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14797)
Reports (19)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (332)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (102)
Last 7 days (434)
Last 30 days (1676)
Last 365 days (19108)
2026 (12047)
2025 (19262)
2024 (22986)
2023 (26539)
2022 (34588)
2021 (37176)
2020 (33480)
2019 (23256)
2018 (17468)
2017 (18767)
2016 (17920)
2015 (24263)
2014 (21684)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17887)
Australia (2097)
California (11901)
Canada (3123)
China (517)
Colorado (480)
Connecticut (407)
Delaware (207)
Europe (24625)
Florida (1780)
Georgia (374)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1194)
Massachusetts (7823)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2608)
New Mexico (12)
New York (2807)
North Carolina (1267)
North Dakota (4)
Northern California (5957)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2245)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4941)
Tennessee (119)
Texas (1921)
United States (38649)
Utah (357)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (920)
West Virginia (1)
Wisconsin (73)
484,544 Results for "vaxart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Leadership
Vaxart seeks shareholder support as battle over stock split brews
In September last year, a group of concerned stockholders raised alarm about Vaxart’s proposed reverse stock split, which the biotech was pushing for despite strong opposition from shareholders.
May 21, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart to Participate in BTIG Biotechnology Conference 2026
July 21, 2026
·
1 min read
Press Releases
Vaxart Announces Results of Annual Meeting of Stockholders 2026
July 19, 2026
·
6 min read
Press Releases
Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
·
10 min read
Press Releases
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
July 30, 2026
·
1 min read
Press Releases
Vaxart to Participate in BTIG Infectious Disease Day 2026
June 9, 2026
·
1 min read
Press Releases
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
July 1, 2026
·
5 min read
Vaccines
HHS Freezes Vaxart’s Oral COVID-19 Vaccine, Again
The stop order came on Aug. 5, the same day Health Secretary Robert F. Kennedy Jr. terminated 22 mRNA vaccine projects under the Biomedical Advanced Research and Development Authority, though Vaxart’s candidate is protein-based.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
June 15, 2026
·
1 min read
Press Releases
Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
May 8, 2026
·
12 min read
1 of 48,455
Next
